<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2024-5854</article-id><article-id custom-type="edn" pub-id-type="custom">NLOUYV</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-5854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Перспективы прогнозирования и профилактики ухудшения течения хронической сердечной недостаточности: аналитический обзор</article-title><trans-title-group xml:lang="en"><trans-title>Prospects for predicting and preventing the heart failure deterioration: an analytical review</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7825-5597</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларина</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Larina</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ларина Вера Николаевна — д.м.н., профессор, зав. кафедрой поликлинической терапии лечебного факультета</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">larinav@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0852-4349</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скиба</surname><given-names>И. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Skiba</surname><given-names>I. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скиба Иван Константинович — ординатор кафедры поликлинической терапии лечебного факультета</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">skibaivan1@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Российский национальный исследовательский медицинский университет имени Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>06</month><year>2024</year></pub-date><volume>29</volume><issue>9</issue><fpage>5854</fpage><lpage>5854</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ларина В.Н., Скиба И.К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ларина В.Н., Скиба И.К.</copyright-holder><copyright-holder xml:lang="en">Larina V.N., Skiba I.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/5854">https://russjcardiol.elpub.ru/jour/article/view/5854</self-uri><abstract><p>Хроническая сердечная недостаточность (ХСН) — синдром, характеризующийся прогрессирующим течением с различной продолжительностью периодов стабильности, частыми эпизодами ухудшения клинического состояния, несмотря на проводимую терапию. Ухудшение течения ХСН часто приводит к повторным госпитализациям и ухудшению прогноза. Возможное снижение частоты повторных госпитализаций и улучшение прогноза путем раннего назначения оптимальной медикаментозной терапии и модернизации немедикаментозных подходов является актуальным направлением для исследований. Комплексный подход с использованием шкал, алгоритмов и актуальных стратегий терапии может значительно улучшить результаты лечения и качество жизни пациентов с ХСН.</p></abstract><trans-abstract xml:lang="en"><p>Heart failure (CHF) is a syndrome characterized by a progressive course with varying duration of stability period, frequent episodes of clinical deterioration, despite the therapy. HF deterioration often leads to repitalizations and poor prognosis. A possible reduction in rehospitalization rate and prognosis improvement by early administration of optimal therapy and modernization of non-drug approaches is an urgent area of research. An integrated approach using scales, algorithms and relevant therapy strategies can significantly improve treatment outcomes and quality of life in patients with HF.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечная недостаточность</kwd><kwd>госпитализация</kwd><kwd>прогноз</kwd><kwd>профилактика</kwd><kwd>социально-экономические факторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure</kwd><kwd>hospitalization</kwd><kwd>prognosis</kwd><kwd>prevention</kwd><kwd>socio-economic factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Packer M.Acute Heart Failure Is an Event Rather Than a Disease: Plea for a Radical Change in Thinking and in Therapeutic Drug Development. JACC Heart Fail. 2018;6(1): 73-5. doi:10.1016/j.jchf.2017.05.008.</mixed-citation><mixed-citation xml:lang="en">Packer M.Acute Heart Failure Is an Event Rather Than a Disease: Plea for a Radical Change in Thinking and in Therapeutic Drug Development. JACC Heart Fail. 2018;6(1): 73-5. doi:10.1016/j.jchf.2017.05.008.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Козиолова Н.А., Миронова С.В., Улыбина Е.В. Развитие острой декомпенсации сердечной недостаточности у больных с предиабетом: связь с факторами риска и коморбидной патологией. Российский кардиологический журнал. 2023;28(3):5373. doi:10.15829/1560-4071-2023-5373.</mixed-citation><mixed-citation xml:lang="en">Koziolova NA, Mironova SV, Ulybina EV. Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities. Russian Journal of Cardiology. 2023;28(3):5373. (In Russ.) doi:10.15829/1560-4071-2023-5373.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина В.Н., Кокорин В.А., Ларин В.Г. и др. Декомпенсация хронической сердечной недостаточности: новый взгляд на проблему в свете обновленного консенсуса экспертов Европейского общества кардиологов. Российский кардиологический журнал. 2023; 28(12):5581. doi:10.15829/1560-4071-2023-5581.</mixed-citation><mixed-citation xml:lang="en">Larina VN, Kokorin VA, Larin VG, et al. Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology. Russian Journal of Cardiology. 2023;28(12):5581. (In Russ.) doi:10.15829/1560-4071-2023-5581.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. doi:10.1016/S0140-6736(20)30925-9.</mixed-citation><mixed-citation xml:lang="en">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. doi:10.1016/S0140-6736(20)30925-9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков Д.С., Фомин И.В., Беленков Ю.Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14. doi:10.18087/cardio.2021.4.n1628.</mixed-citation><mixed-citation xml:lang="en">Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. (In Russ.) doi:10.18087/cardio.2021.4.n1628.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682- 90. doi:10.1093/eurjpc/zwaa147.</mixed-citation><mixed-citation xml:lang="en">Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682- 90. doi:10.1093/eurjpc/zwaa147.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber Y, Weston SA, Redfield MM, et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 2015;175:996- 1004. doi:10.1001/jamainternmed.2015.0924.</mixed-citation><mixed-citation xml:lang="en">Gerber Y, Weston SA, Redfield MM, et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 2015;175:996- 1004. doi:10.1001/jamainternmed.2015.0924.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep. 2014;11:404-15. doi:10.1007/s11897-014-0220-x.</mixed-citation><mixed-citation xml:lang="en">Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep. 2014;11:404-15. doi:10.1007/s11897-014-0220-x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333-41. doi:10.1056/NEJMoa1406656.</mixed-citation><mixed-citation xml:lang="en">Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333-41. doi:10.1056/NEJMoa1406656.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Жиров И.В., Насонова С.Н., Халилова У.А. и др. Острая сердечная недостаточность: классификация, диагностика, общие подходы к лечению. Consilium Medicum. 2021;23(10):750-5. doi:10.26442/20751753.2021.10.200980.</mixed-citation><mixed-citation xml:lang="en">Zhirov IV, Nasonova SN, Khalilova UA, et al. Acute heart failure: classification, diagnosis, general approaches to treatment. Consilium Medicum. 2021;23(10):750-5. (In Russ.) doi:10.26442/20751753.2021.10.200980.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kristjánsdóttir I, Thorvaldsen T, Lund LH. Congestion and Diuretic Resistance in Acute or Worsening Heart Failure, Cardiac Failure Review. 2020;6:e25. doi:10.15420/cfr.2019.18.</mixed-citation><mixed-citation xml:lang="en">Kristjánsdóttir I, Thorvaldsen T, Lund LH. Congestion and Diuretic Resistance in Acute or Worsening Heart Failure, Cardiac Failure Review. 2020;6:e25. doi:10.15420/cfr.2019.18.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Greene SJ, Bauersachs J, Brugts JJ, et al. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;4(81):413-24. doi:10.1016/j.jacc.2022.11.023.</mixed-citation><mixed-citation xml:lang="en">Greene SJ, Bauersachs J, Brugts JJ, et al. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;4(81):413-24. doi:10.1016/j.jacc.2022.11.023.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Packer M, O'Connor C, McMurray JJ, et al., TRUE-AHF Investigators. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med. 2017;376:1956-64. doi:10.1056/NEJMoa1601895.</mixed-citation><mixed-citation xml:lang="en">Packer M, O'Connor C, McMurray JJ, et al., TRUE-AHF Investigators. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med. 2017;376:1956-64. doi:10.1056/NEJMoa1601895.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Miró Ò, Rossello X, Platz E, et al. Study Group on Acute Heart Failure of the Acute Cardiovascular Care Association of the European Society of Cardiology. Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review. Eur Heart J Acute Cardiovasc Care. 2020;9(5):375-98. doi:10.1177/2048872620930889.</mixed-citation><mixed-citation xml:lang="en">Miró Ò, Rossello X, Platz E, et al. Study Group on Acute Heart Failure of the Acute Cardiovascular Care Association of the European Society of Cardiology. Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review. Eur Heart J Acute Cardiovasc Care. 2020;9(5):375-98. doi:10.1177/2048872620930889.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Metra M, Tomasoni D, Adamo M, et al. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 25(6):776-91. doi:10.1002/ejhf.2874.</mixed-citation><mixed-citation xml:lang="en">Metra M, Tomasoni D, Adamo M, et al. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 25(6):776-91. doi:10.1002/ejhf.2874.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Inácio H, De Carvalho A, Gamelas De Carvalho J, et al. Real-Life Data on Readmissions of Worsening Heart Failure Outpatients in a Heart Failure Clinic. Cureus. 2023;15(2): e35611. doi:10.7759/cureus.35611.</mixed-citation><mixed-citation xml:lang="en">Inácio H, De Carvalho A, Gamelas De Carvalho J, et al. Real-Life Data on Readmissions of Worsening Heart Failure Outpatients in a Heart Failure Clinic. Cureus. 2023;15(2): e35611. doi:10.7759/cureus.35611.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Айрапетян А.А., Лазарева Н.В., Рейтблат О.М. и др. Коморбидные состояния у пациентов с хронической сердечной недостаточностью (по данным регистра хронической сердечной недостаточности в Тюменской области). Consilium Medicum. 2023;25(10):685-92. doi:10.26442/20751753.2023.10.202384.</mixed-citation><mixed-citation xml:lang="en">Airapetian AA, Lazareva NV, Reitblat OM, et al. Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region). Consilium Medicum. 2023;25(10):685-92. (In Russ.) doi:10.26442/20751753.2023.10.202384.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е.В., Беленков Ю.Н., Бойцов С.А. и др. Проспективное наблюдательное многоцентровое регистровое исследование пациентов с хронической сердечной недостаточностью в Российской Федерации (ПРИОРИТЕТХСН): обоснование, цели и дизайн исследования. Российский кардиологический журнал. 2023;28(6):5456. doi:10.15829/1560-4071-2023-5456.</mixed-citation><mixed-citation xml:lang="en">Shlyakhto EV, Belenkov YuN, Boytsov SI, et al. Prospective observational multicenter registry study of patients with heart failure in the Russian Federation (PRIORITETCHF): rationale, objectives and design of the study. Russian Journal of Cardiology. 2023;28(6):5456. (In Russ.) doi:10.15829/1560-4071-2023-5456.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng L, Smith NJ, Teng BQ, et al. Predictive Model for Heart Failure Readmission Using Nationwide Readmissions Database. Mayo Clin Proc Innov Qual Outcomes. 2022; 6(3):228-38. doi:10.1016/j.mayocpiqo.2022.04.002.</mixed-citation><mixed-citation xml:lang="en">Zheng L, Smith NJ, Teng BQ, et al. Predictive Model for Heart Failure Readmission Using Nationwide Readmissions Database. Mayo Clin Proc Innov Qual Outcomes. 2022; 6(3):228-38. doi:10.1016/j.mayocpiqo.2022.04.002.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh T, Metra М, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627-39. doi:10.1093/eurheartj/ehad195. Erratum in Eur Heart J. 2024; 45(1):53. doi: 10.1093/eurheartj/ehad613.</mixed-citation><mixed-citation xml:lang="en">McDonagh T, Metra М, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627-39. doi:10.1093/eurheartj/ehad195. Erratum in Eur Heart J. 2024; 45(1):53. doi: 10.1093/eurheartj/ehad613.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Лопатин Ю.М., Арутюнов Г.П., Аметов А.С. др. Применение эмпаглифлозина у пациентов, госпитализированных по поводу острой декомпенсации сердечной недостаточности: резолюция экспертов по результатам обсуждения исследования EMPULSE. Российский кардиологический журнал. 2022;27(3):4945. doi:10.15829/1560-4071-2022-4945.</mixed-citation><mixed-citation xml:lang="en">Lopatin YuM, Arutyunov GP, Ametov AS, et al. Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial. Russian Journal of Cardiology. 2022;27(3):4945. (In Russ.) doi:10.15829/1560-4071-2022-4945.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mebazaa A, Cohen Solal A, Colombo PC. Assessing and treating congestion in acute decompensated heart failure: are we seeing the light at the end of the tunnel? European Heart Journal. 2023;44(1):51-3. doi:10.1093/eurheartj/ehac680.</mixed-citation><mixed-citation xml:lang="en">Mebazaa A, Cohen Solal A, Colombo PC. Assessing and treating congestion in acute decompensated heart failure: are we seeing the light at the end of the tunnel? European Heart Journal. 2023;44(1):51-3. doi:10.1093/eurheartj/ehac680.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014;1(2):110-45. doi:10.1002/ehf2.12021.</mixed-citation><mixed-citation xml:lang="en">Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014;1(2):110-45. doi:10.1002/ehf2.12021.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Borovac JA. Early in-hospital initiation and optimization of comprehensive diseasemodifying pharmacotherapy in patients with heart failure with reduced ejection fraction: a time for the paradigm shift, Expert Review of Cardiovascular Therapy. 2022;20(2):91-4. doi:10.1080/14779072.2022.2039626.</mixed-citation><mixed-citation xml:lang="en">Borovac JA. Early in-hospital initiation and optimization of comprehensive diseasemodifying pharmacotherapy in patients with heart failure with reduced ejection fraction: a time for the paradigm shift, Expert Review of Cardiovascular Therapy. 2022;20(2):91-4. doi:10.1080/14779072.2022.2039626.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Виллевальде C.В., Соловьева А.Е., Звартау Н.Э. и др. Принципы организации медицинской помощи пациентам с сердечной недостаточностью в системе управления сердечно-сосудистыми рисками: фокус на преемственность и маршрутизацию пациентов. Практические материалы. Российский кардиологический журнал. 2021;26(3S):4558. doi:10.15829/1560-4071-2021-4558.</mixed-citation><mixed-citation xml:lang="en">Villevalde SV, Soloveva AE, Zvartau NE, et al. Principles of organization of medical care for patients with heart failure in the system of cardiovascular risk management: focus on continuity of care and patient routing. Practical materials. Russian Journal of Cardiology. 2021;26(3S):4558. (In Russ.) doi:10.15829/1560-4071-2021-4558.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж.Д., Толкачева В.В., Сарлыков Б.К. и др. Интегральная оценка застоя у пациентов с острой декомпенсацией хронической сердечной недостаточности. Российский кардиологический журнал. 2022;27(2):4799. doi:10.15829/1560-4071-2022-4799.</mixed-citation><mixed-citation xml:lang="en">Kobalava ZhD, Tolkacheva VV, Sarlykov BK, et al. Integral assessment of congestion in patients with acute decompensated heart failure. Russian Journal of Cardiology. 2022;27(2):4799. (In Russ.) doi:10.15829/1560-4071-2022-4799.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rubio-Gracia J, Demissei BG, ter Maaten JM, et al. Prevalence, predictors and clinica outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018;258:185-91. doi:10.1016/j.ijcard.2018.01.067.</mixed-citation><mixed-citation xml:lang="en">Rubio-Gracia J, Demissei BG, ter Maaten JM, et al. Prevalence, predictors and clinica outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018;258:185-91. doi:10.1016/j.ijcard.2018.01.067.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
